Showing results (431-440 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2023
Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature ReviewRafael Fonseca, Diana Tran, Alyshia Laidlaw, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 13, 2023
Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual WorkshopEvangelos Terpos, Paola Neri, Niels W C J van de Donk, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2023
FDA Analysis of Ineligibility for Acute Myeloid Leukemia Clinical Trials by Race and EthnicityDianne Pulte, Laura Fernandes, Guo Wei, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 18, 2020
Effect of Prophylactic Post-transplant Ponatinib Administration on Outcomes in Patients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaSatoru Nanno, Kana Matsumoto, Mika Nakamae, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 4, 2023
SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on TargetShannon A Carty, Carlos A Murga-Zamalloa, Ryan A Wilcox
Clinical Lymphoma, Myeloma & Leukemia|August 11, 2020
Impact of Insurance Status on Survival Outcomes in Adults With Acute Lymphoblastic Leukemia (ALL): A Single-center ExperienceRebecca Krakora, Weichung Shih, Pallvi Popli, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2021
Transition from Intravenous to Subcutaneous Daratumumab Formulation in Clinical PracticeIssam S Hamadeh, Donald C Moore, Allison Martin, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 19, 2020
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the LiteratureBethany E Monteith, Christopher P Venner, Donna E Reece, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2020
Influence of Rurality, Race, and Ethnicity on Non-Hodgkin Lymphoma IncidenceDeanna Blansky, Ioannis Mantzaris, Thomas Rohan, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2020
A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related ToxicityMahmut Yeral, Pelin Aytan, Burcu Gungor, et al.
Pageof 251